Family Services of Western Pennsylvania Clozaril/Clozapine Clinic
Behavioral Health Services
Send the URL of this service profile via SMS text message.
Data Provided By
United Way of Allegheny County
Description of Service
The Outpatient Clozaril Clinic is designed for individuals in service who are prescribed Clozaril/Clozapine medication. There is a risk of agranulocytosis, a potentially life-threatening adverse effect that can cause a drop in WBC (white blood cell count), decreasing an individual’s ability to fight infection. When it is determined to be medically necessary to prescribe Clozaril/Clozapine, baseline bloodwork must be obtained. Once medication is started, weekly monitoring of bloodwork is required for the first six months of treatment, then bi-weekly for six months, followed by monthly monitoring thereafter. Individuals are seen monthly by a nurse for assessment of psychiatric symptoms, side effects, signs of infection, adherence, vital signs and general stability. Bloodwork is obtained and a one month supply of medication is provided. Individuals are also followed medically by the psychiatrist on a regular basis. Bloodwork results are reviewed by MD, nurse and pharmacist and reported to the national registry.
Adult Continuing Care Referral, Crisis Therapist or Single Point of Access
1) Individuals diagnosed with Schizophrenia who are determined in need of Clozaril/Clozapine treatment, and
2) White Blood Count (WBC) baseline and Differential counts higher than 3500/mm3, ANC 1500 and
3) Registered with Clorzaril/Clozapine National Registry and as long as WBC count remains above 3000/mm3 and is tested as per protocol.
If WBC that drops below 2000mm3 or the granulocyte count drops below 1000mm3, Clozaril/Clozapine therapy must be discontinued and can never be resumed because of the risk of agranulocytosis recurrence is increased greatly.
Hours of Operation
Weekdays, 8:30am to 5:00pm Evening hours vary by office location